Key facts
- Notable investors include Gongqingcheng Qingchuang Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhongke Hangchuang
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Hangchuang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Hangchuang
Developer of neurotechnology systems intended to regulate mental health conditions through advanced brain-computer interface applications. The company offers invasive neural interface technology, closed-loop regulation mechanisms, and integrated data-driven control frameworks for clinical environments, enabling healthcare providers and research institutions to deliver precise therapeutic interventions and advance treatment methodologies for complex psychiatric disorders within controlled and secure settings.
- Sector
- Healthcare
- HQ
- Xiangyang, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Zhongke Hangchuang doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Hangchuang shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Hangchuang in its N-PORT filings yet. We sweep new filings monthly.